These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 34578352)

  • 21. Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody.
    Esswein SR; Gristick HB; Jurado A; Peace A; Keeffe JR; Lee YE; Voll AV; Saeed M; Nussenzweig MC; Rice CM; Robbiani DF; MacDonald MR; Bjorkman PJ
    Proc Natl Acad Sci U S A; 2020 May; 117(18):9865-9875. PubMed ID: 32321830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of serological and molecular methods for diagnosis of zika virus infections.
    Jääskeläinen AJ; Korhonen EM; Huhtamo E; Lappalainen M; Vapalahti O; Kallio-Kokko H
    J Virol Methods; 2019 Jan; 263():68-74. PubMed ID: 30342068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of novel rapid detection kits for dengue virus NS1 antigen in Dhaka, Bangladesh, in 2017.
    Suzuki K; Nakayama EE; Saito A; Egawa A; Sato T; Phadungsombat J; Rahim R; Hasan A; Iwamoto H; Rahman M; Shioda T
    Virol J; 2019 Aug; 16(1):102. PubMed ID: 31416485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specificity of NS1-based immunochromatographic tests for dengue virus with regard to the Zika virus protein.
    Andreata-Santos R; Pereira SS; Pereira LR; Félix AC; Romano CM; Ferreira LCS
    Int J Infect Dis; 2020 Jun; 95():276-278. PubMed ID: 32289563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained Specific and Cross-Reactive T Cell Responses to Zika and Dengue Virus NS3 in West Africa.
    Herrera BB; Tsai WY; Chang CA; Hamel DJ; Wang WK; Lu Y; Mboup S; Kanki PJ
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a novel NS1 competitive enzyme-linked immunosorbent assay for the early detection of Zika virus infection.
    Roldán JS; Cassola A; Castillo DS
    PLoS One; 2021; 16(8):e0256220. PubMed ID: 34403457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NS1-Specific Antibody Response Facilitates the Identification of Children With Dengue and Zika in Hyperendemic Areas.
    Castro-Trujillo S; Segura K; Bolívar-Marín S; Salgado DM; Bosch I; Vega R; Rojas MC; Narváez CF
    Pediatr Infect Dis J; 2024 Feb; 43(2):178-185. PubMed ID: 37963312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection.
    Slon Campos JL; Poggianella M; Marchese S; Mossenta M; Rana J; Arnoldi F; Bestagno M; Burrone OR
    PLoS One; 2017; 12(7):e0181734. PubMed ID: 28742857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zika Virus Peptide ELISA (ZIKV-NS2B-Concat ELISA) for Detection of IgG Antibodies to Zika Virus Infection.
    Mishra N; Thakkar R; Ng J; Lipkin WI
    Methods Mol Biol; 2020; 2142():113-122. PubMed ID: 32367363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development.
    Elong Ngono A; Shresta S
    Front Immunol; 2019; 10():1316. PubMed ID: 31244855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections.
    Rönnberg B; Gustafsson Å; Vapalahti O; Emmerich P; Lundkvist Å; Schmidt-Chanasit J; Blomberg J
    Med Microbiol Immunol; 2017 Oct; 206(5):383-401. PubMed ID: 28852878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T Cell Responses to Nonstructural Protein 3 Distinguish Infections by Dengue and Zika Viruses.
    Herrera BB; Tsai WY; Brites C; Luz E; Pedroso C; Drexler JF; Wang WK; Kanki PJ
    mBio; 2018 Aug; 9(4):. PubMed ID: 30087165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-existing T Cell Memory against Zika Virus.
    Schouest B; Grifoni A; Pham J; Mateus J; Sydney J; Brien JD; De Silva AD; Balmaseda A; Harris E; Sette A; Weiskopf D
    J Virol; 2021 May; 95(12):. PubMed ID: 33789994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a quantitative NS1 antigen enzyme-linked immunosorbent assay (ELISA) for Zika virus detection using a novel virus-specific mAb.
    Morales SV; Coelho GM; Ricciardi-Jorge T; Dorl GG; Zanluca C; Duarte Dos Santos CN
    Sci Rep; 2024 Jan; 14(1):2544. PubMed ID: 38291109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop.
    Rockstroh A; Moges B; Barzon L; Sinigaglia A; Palù G; Kumbukgolla W; Schmidt-Chanasit J; Sarno M; Brites C; Moreira-Soto A; Drexler JF; Ferreira OC; Ulbert S
    Emerg Microbes Infect; 2017 Nov; 6(11):e99. PubMed ID: 29116222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and application of yellow fever virus NS1 protein-specific monoclonal antibodies.
    Liu D; Chen D; Zhang T; Yu N; Ren R; Chen Y; Wang C
    J Med Virol; 2021 Jun; 93(6):3374-3382. PubMed ID: 32841419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and Evaluation of a Universal and Supersensitive NS1-Based Luciferase Immunosorbent Assay to Detect Zika Virus-Specific IgG.
    Wang T; Zhan Y; Wu D; Chen Z; Wu W; Deng Y; Wang W; Tan W; Tang S
    Virol Sin; 2020 Feb; 35(1):93-102. PubMed ID: 31552611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Anti-Dengue and Anti-Zika IgG on a Plasmonic Gold Platform with Neutralization Testing.
    Rojas A; Natrajan MS; Weber J; Cardozo F; Cantero C; Ananta JS; Kost J; Tang M; López S; Bernal C; Guillén Y; Mendoza L; Páez M; Pinsky BA; Waggoner JJ
    Am J Trop Med Hyg; 2021 Mar; 104(5):1729-1733. PubMed ID: 33782214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction.
    Biering SB; Akey DL; Wong MP; Brown WC; Lo NTN; Puerta-Guardo H; Tramontini Gomes de Sousa F; Wang C; Konwerski JR; Espinosa DA; Bockhaus NJ; Glasner DR; Li J; Blanc SF; Juan EY; Elledge SJ; Mina MJ; Beatty PR; Smith JL; Harris E
    Science; 2021 Jan; 371(6525):194-200. PubMed ID: 33414220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.